Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00295139 · ClinicalTrials.gov registry record · NA
Behavioral Treatment of Drug Abuse in Severe and Persistent Mental Illness (SPMI) Patients
A NA study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 293
- Enrollment target
NCT00295139: Completed NA study, sponsored by University of Maryland, Baltimore.
NCT00295139 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 293 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00295139, a NA study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 293 participants
- Enrollment target
Study Summary
The main purpose of this study is to determine if the multifaceted treatment for substance abuse in dual disordered patients is more effective in reducing drug use than a supportive control treatment. The researchers will also determine if adding a case management component (Critical Time Intervention; CTI) to the intervention will increase treatment engagement and retention.
Interventions
- BEHAVIORAL Critical Time Intervention (CTI)
- BEHAVIORAL Behavioral Treatment for Substance Abuse in SPMI (BTSAS)
- BEHAVIORAL Supportive Treatment in Addiction Recovery (STAR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 293 participants |
| Start Date | 2005-01 |
| Est. Completion | 2010-03 |
| Phase | NA |
What the finished NCT00295139 record still lists
NCT00295139 is an interventional study that assigns participants to a tested intervention. The registered 293 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 3 interventions - of which Critical Time Intervention (CTI) is the first listed.
NCT00295139 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00295139 about?
NCT00295139 is a clinical study titled "Behavioral Treatment of Drug Abuse in Severe and Persistent Mental Illness (SPMI) Patients". The main purpose of this study is to determine if the multifaceted treatment for substance abuse in dual disordered patients is more effective in reducing drug use than a supportive control treatment. The researchers will also determine if adding a case management component (Critical Time Interventi...
What is the current status of trial NCT00295139?
This trial is currently completed. It is a NA study. The enrollment target is 293 participants. The study started on 2005-01. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00295139?
The interventions under investigation include: Critical Time Intervention (CTI) (BEHAVIORAL), Behavioral Treatment for Substance Abuse in SPMI (BTSAS) (BEHAVIORAL), Supportive Treatment in Addiction Recovery (STAR) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00295139?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00295139's enrollment target sits among peer trials
293 375th of 2000 higher than 1,626 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05775159 · 294 participants · Phase 2
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
- NCT06262113 · 294 participants · NA
A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1
- NCT06338865 · 294 participants · NA
Short Title: Standard vs. Lower Pressure Pneumoperitoneum
- NCT06395467 · 294 participants · NA
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia